Metaraminol bitartrate bulk drug storage device

By designing a rotatable connecting shaft and gear system, the placement frame is in a backward or forward tilted state, the problem of inconvenient storage and access of medicines in existing storage devices is solved, and the convenient storage and access of medicines is achieved.

CN222023107UActive Publication Date: 2024-11-19KAIKAII YUANSHENG PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420463487.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-03-11
Publication Date
2024-11-19
Estimated Expiration
2034-03-11

AI Technical Summary

Technical Problem

The existing storage device for heavy tartaric acid interhydroxylamine raw materials is not convenient for the storage and access of bottled drugs, and there is difficulty in frequent placement and picking up.

Method used

A storage device including a cabinet body, a light shielding plate with a shaft hinged together, a connecting shaft distributed in the upper and lower directions, a placement frame, a gear and a rack that can be moved up and down, is designed, and the placement frame is tilted backward or front by rotating the connecting shaft. In a state of tilting, it realizes convenient placement and removal of drugs.

Benefits of technology

This device enables the hydroxylamine raw materials of heavy tartaric acid to be conveniently placed and taken, avoid frequent placement and improves the storage and use efficiency of drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222023107U_ABST
    Figure CN222023107U_ABST
Patent Text Reader

Abstract

The utility model relates to a metaraminol bitartrate bulk drug storage device which comprises a cabinet body, two shading plates are hinged to the front side of the cabinet body through rotating shafts, a plurality of connecting shafts which are evenly distributed in the vertical direction are rotationally connected into the cabinet body, placing frames are fixed to the connecting shafts, and baffles are hinged to the front sides of the placing frames. One end of the connecting shaft extends out of the cabinet body and is fixedly provided with a gear, and one side of the cabinet body is provided with a rack capable of moving up and down. When a bottled metaraminol bitartrate raw material medicine needs to be placed on the placing frame, the connecting shaft is rotated to enable the placing frame to be in a backward inclined state, so that after the bottled metaraminol bitartrate raw material medicine is placed on the placing frame, the medicine can slide to the rear side of the placing frame, the situation that the medicine is frequently placed is avoided, and when the medicine is taken, the connecting shaft is rotated, so that the medicine can be conveniently taken. According to the metaraminol bitartrate storage device, the containing frame is in a forward inclined state, after the medicine on the front side is taken away, the medicine on the rear side can slide to the front side, and therefore bottled metaraminol bitartrate raw medicine can be conveniently stored and taken through the metaraminol bitartrate storage device.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to a medicine storage technology, in particular to a storage device for meta-hydroxylamine bitartrate raw material medicine. Background Art

[0002] Metahydroxylamine bitartrate is the bitartrate salt of metahydroxylamine, an α-adrenaline receptor agonist that mainly acts on α receptors. It is suitable for the early treatment of shock and the prevention and treatment of acute hypotension during spinal block anesthesia. After metahydroxylamine bitartrate is injected into the human body, it can be taken up by adrenergic nerve endings, promote the release of norepinephrine from adrenergic nerve endings, and exert an adrenaline-mimetic effect.

[0003] At present, the storage of meta-hydroxylamine bitartrate API needs to be shielded from light and stored in a sealed manner. The existing storage devices for bottled meta-hydroxylamine bitartrate API are often not convenient for storing and taking out the bottled meta-hydroxylamine bitartrate API. Utility Model Content

[0004] The utility model aims to provide a storage device for meta-hydroxylamine bitartrate raw material medicine, which is used to solve the problem that the existing storage device for meta-hydroxylamine bitartrate raw material medicine is often inconvenient for storing and taking the meta-hydroxylamine bitartrate raw material medicine.

[0005] In order to solve the above problems, the utility model provides a storage device for meta-hydroxylamine bitartrate raw materials, comprising a cabinet body, wherein two shading plates are hingedly connected to the front side of the cabinet body via a rotating shaft, a plurality of connecting shafts uniformly distributed in the up and down directions are rotatably connected in the cabinet body, a placement frame is fixed on the connecting shaft, a baffle is hingedly connected to the front side of the placement frame, one end of the connecting shaft extends out of the cabinet body and is fixed with a gear, and a rack that can move up and down is provided on one side of the cabinet body, and the rack can mesh with a plurality of gears.

[0006] The storage device for meta-hydroxylamine bitartrate raw material medicine provided by the utility model also has the following technical features:

[0007] Furthermore, a positioning bolt is threadedly connected to one side of the baffle, and a positioning hole is opened on one side of the placement frame, and one end of the positioning bolt can be inserted into the corresponding positioning hole.

[0008] Furthermore, a limit seat is fixed on one side of the cabinet, and the rack can move up and down in the limit seat.

[0009] Furthermore, a protective shell is fixed on one side of the cabinet, the rack and the gear are both located in the protective shell, a limit hole is provided on the protective shell, a connecting rod is fixed on the rack, one end of the connecting rod can extend out of the limit hole and is threadedly connected to a swivel seat.

[0010] Furthermore, a top ring is fixed to one side of the rotating seat, and one side of the top ring can contact with the surface of the protective shell.

[0011] Furthermore, a bottom cabinet is fixed to the lower side of the cabinet body, and two cabinet doors are rotatably connected to the front side of the bottom cabinet.

[0012] The utility model has the following beneficial effects: when it is necessary to place bottled meta-hydroxylamine bitartrate raw materials on the placement frame, the connecting shaft is rotated so that the placement frame is in a backward tilted state, so that after the bottled meta-hydroxylamine bitartrate raw materials are placed on the placement frame, the medicine can slide to the rear side of the placement frame, thereby avoiding frequent placement of the position, and when taking the medicine, the connecting shaft is rotated so that the placement frame is in a forward tilted state, after the medicine on the front side is taken away, the medicine on the rear side can slide to the front side, thereby making the device convenient for storing and taking the bottled meta-hydroxylamine bitartrate raw materials. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 It is an axonometric diagram of an embodiment of the utility model;

[0014] Figure 2 This is an axonometric diagram of an embodiment of the utility model after removing the sunshade and the cabinet door;

[0015] Figure 3 It is a right side cutaway view of a broken embodiment of the utility model;

[0016] Figure 4 It is a right side cutaway view of an embodiment of the utility model;

[0017] Figure 5 It is a top view of a fractured embodiment of the utility model. DETAILED DESCRIPTION

[0018] The present invention will be described in detail below with reference to the accompanying drawings and in combination with embodiments. It should be noted that the embodiments and features in the embodiments of the present invention can be combined with each other without conflict.

[0019] like Figures 1 to 5In the embodiment of the storage device for meta-hydroxylamine bitartrate of the utility model shown, the storage device for meta-hydroxylamine bitartrate of the utility model comprises a cabinet 1, the front side of the cabinet 1 is hinged with two shading plates 2 via a rotating shaft, a plurality of connecting shafts 3 evenly distributed in the up and down directions are rotatably connected in the cabinet 1, a placement frame 4 is fixed on the connecting shaft 3, a baffle 5 is hinged on the front side of the placement frame 4, one end of the connecting shaft 3 extends out of the cabinet 1 and is fixed with a gear 6, a rack 7 that can move up and down is provided on one side of the cabinet 1, and the rack 7 can mesh with the plurality of gears 6, when it is needed When placing the bottled meta-hydroxylamine bitartrate API on the placement frame 4, the connecting shaft 3 is rotated to make the placement frame 4 tilted backward, so that after the bottled meta-hydroxylamine bitartrate API is placed on the placement frame 4, the medicine can slide to the rear side of the placement frame 4, thereby avoiding frequent placement of the medicine. When taking the medicine, the connecting shaft 3 is rotated to make the placement frame 4 tilted forward, and after taking the medicine on the front side, the medicine on the rear side can slide to the front side, thereby making the device convenient for storing and taking the bottled meta-hydroxylamine bitartrate API.

[0020] In one embodiment of the present application, preferably, a positioning bolt 8 is threadedly connected to one side of the baffle 5, and a positioning hole is opened on one side of the placement frame 4. One end of the positioning bolt 8 can be inserted into the corresponding positioning hole. When placing the medicine, the positioning bolt 8 is separated from the positioning hole so that the baffle 5 does not play a blocking role, thereby facilitating the placement of the medicine.

[0021] In one embodiment of the present application, preferably, a limit seat 9 is fixed on one side of the cabinet 1, and the rack 7 can move up and down in the limit seat 9. By moving the rack 7 up and down, the connecting shaft 3 and the gear 6 can be driven to rotate.

[0022] In one embodiment of the present application, preferably, a protective shell 10 is fixed on one side of the cabinet 1, the rack 7 and the gear 6 are both located in the protective shell 10, a limiting hole 11 is provided on the protective shell 10, a connecting rod 12 is fixed on the rack 7, one end of the connecting rod 12 can extend out of the limiting hole and is threadedly connected with a swivel seat 13, so that the protective shell 10 plays a protective role, and the setting of the limiting hole 11 can limit the rotation angle of the connecting shaft 3 to prevent the placement frame 4 from tipping over due to excessive rotation angle.

[0023] In one embodiment of the present application, preferably, a top ring 14 is fixed to one side of the rotary seat 13, and one side of the top ring 14 can contact the surface of the protective shell 10. By moving the rotary seat 13 up and down, the rack 7 can be driven to move up and down, and by rotating the rotary seat 13, one side of the top ring 14 can contact the surface of the protective shell 10, thereby playing a certain role in fixing the height position of the rotary seat 13.

[0024] In one embodiment of the present application, preferably, a bottom cabinet 15 is fixed to the lower side of the cabinet body 1, and two cabinet doors 16 are rotatably connected to the front side of the bottom cabinet 15. Through the setting of the bottom cabinet 15, some sundries or other medicines can be placed in the bottom cabinet 15.

[0025] When the utility model is in use, when it is necessary to place bottled meta-hydroxylamine bitartrate bulk drug on the placement frame 4, the positioning bolt 8 is separated from the positioning hole, so that the baffle 5 does not play a blocking role, and the movable rotary seat 13 can drive the rack 7 to move upward, so that the placement frame 4 rotates to a backward tilted state, so that after the bottled meta-hydroxylamine bitartrate bulk drug is placed on the placement frame 4, the drug can slide to the rear side of the placement frame 4, thereby avoiding frequent placement of its position, and when taking the drug, the baffle 5 plays a blocking role, and the connecting shaft 3 is rotated to make the placement frame 4 in a forward tilted state. After the drug on the front side is taken away, the drug on the rear side can slide to the front side, so that the device is convenient for storing and taking the bottled meta-hydroxylamine bitartrate bulk drug.

[0026] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the utility model, rather than to limit it. Although the utility model has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the various embodiments of the utility model.

Claims

1. A storage device for meta-hydroxylamine bitartrate raw material medicine, comprising a cabinet (1), It is characterized in that The front side of the cabinet (1) is hinged with two shading plates (2) via a rotating shaft, a plurality of connecting shafts (3) evenly distributed in the vertical direction are rotatably connected inside the cabinet (1), a placement frame (4) is fixed on the connecting shaft (3), a baffle (5) is hinged on the front side of the placement frame (4), one end of the connecting shaft (3) extends out of the cabinet (1) and is fixed with a gear (6), and a rack (7) that can move up and down is provided on one side of the cabinet (1), and the rack (7) can mesh with the plurality of gears (6).

2. The storage device for metahydroxylamine bitartrate bulk drug according to claim 1, Features: One side of the baffle (5) is threadedly connected with a positioning bolt (8), and one side of the placement frame (4) is provided with a positioning hole, and one end of the positioning bolt (8) can be inserted into the corresponding positioning hole.

3. The storage device for meta-hydroxylamine bitartrate bulk drug according to claim 1, Features: A limit seat (9) is fixed on one side of the cabinet (1), and the rack (7) can move up and down in the limit seat (9).

4. The storage device for meta-hydroxylamine bitartrate bulk drug according to claim 3, Features: A protective shell (10) is fixed on one side of the cabinet (1), the rack (7) and the gear (6) are both located in the protective shell (10), a limiting hole (11) is provided on the protective shell (10), a connecting rod (12) is fixed on the rack (7), one end of the connecting rod (12) can extend out of the limiting hole and is threadedly connected to a rotating seat (13).

5. The storage device for metahydroxylamine bitartrate bulk drug according to claim 4, Features: A top ring (14) is fixed to one side of the rotating seat (13), and one side of the top ring (14) can contact the surface of the protective shell (10).

6. The storage device for metahydroxylamine bitartrate bulk drug according to claim 1, Features: A bottom cabinet (15) is fixed to the lower side of the cabinet body (1), and two cabinet doors (16) are rotatably connected to the front side of the bottom cabinet (15).